Zobrazeno 1 - 10
of 299
pro vyhledávání: '"Chelariu-Raicu A"'
Autor:
Tanja Nikolova, Michaela Bossart, Joanna Kacperczyk-Bartnik, Zoia Razumova, Alexandra Strojna, Nicolò Bizzarri, Andrei Pletnev, Natalia R. Gómez-Hidalgo, Charalampos Theofanakis, Maximilian Lanner, Ilker Selcuk, Alexander Shushkevich, Chelariu-Raicu Anca, Natasha Nikolova, Nicole Concin, Kamil Zalewski
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionGender-related differences in career development are well known issues in various professions. An international survey on gender-related differences was performed among young gynecologic oncology surgeons in Europe to identify potential g
Externí odkaz:
https://doaj.org/article/45876a653da0477888fdda12552e91ab
Autor:
Fabian B. T. Kraus, Elena Sultova, Kathrin Heinrich, Andreas Jung, C. Benedikt Westphalen, Christina V. Tauber, Jörg Kumbrink, Martina Rudelius, Frederick Klauschen, Philipp A. Greif, Alexander König, Anca Chelariu-Raicu, Bastian Czogalla, Alexander Burges, Sven Mahner, Rachel Wuerstlein, Fabian Trillsch
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 4, p 2345 (2024)
Advances in molecular tumor diagnostics have transformed cancer care. However, it remains unclear whether precision oncology has the same impact and transformative nature across all malignancies. We conducted a retrospective analysis of patients with
Externí odkaz:
https://doaj.org/article/bef91cea36b9475bbf8817dfe82ed9cb
Autor:
Batz, Falk, Lermer, Eva, Hatzler, Laura, Vilsmaier, Theresa, Schröder, Lennard, Chelariu-Raicu, Anca, Behr, Joachim, Mahner, Sven, Buspavanich, Pichit, Thaler, Christian J.
Publikováno v:
In The Journal of Sexual Medicine June 2022 19(6):907-922
Autor:
Susann Badmann, Doris Mayr, Elisa Schmoeckel, Anna Hester, Christina Buschmann, Susanne Beyer, Thomas Kolben, Fabian Kraus, Anca Chelariu-Raicu, Alexander Burges, Sven Mahner, Udo Jeschke, Fabian Trillsch, Bastian Czogalla
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract In recurrent epithelial ovarian cancer (EOC) most patients develop platinum-resistance. On molecular level the NRF2 pathway, a cellular defense mechanism against reactive oxygen species, is induced. In this study, we investigate AKR1C1/2, ta
Externí odkaz:
https://doaj.org/article/51dfe0d42da94dd1b154d81478a61c37
Autor:
Marie Forster, Rachel Wuerstlein, Alexander Koenig, Niklas Amann, Susanne Beyer, Till Kaltofen, Tom Degenhardt, Alexander Burges, Fabian Trillsch, Sven Mahner, Nadia Harbeck, Anca Chelariu-Raicu
Publikováno v:
Breast, Vol 60, Iss , Pp 214-222 (2021)
Introduction: The side effects of systemic cancer therapy and the lack of clinical data on safety and efficacy of COVID-19 vaccination in cancer patients cause uncertainty among the patients about whether to get vaccinated or not. Here, we evaluated
Externí odkaz:
https://doaj.org/article/c56b223aaf9545459022a504855c2e26
Autor:
Chelariu-Raicu, Anca, Nick, Alpa, Urban, Renata, Gordinier, Mary, Leuschner, Carola, Bavisotto, Linda, Molin, Graziela Zibetti Dal, Whisnant, John K., Coleman, Robert L.
Publikováno v:
In Gynecologic Oncology February 2021 160(2):418-426
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yunfei Wen, Anca Chelariu-Raicu, Sujanitha Umamaheswaran, Alpa M. Nick, Elaine Stur, Pahul Hanjra, Dahai Jiang, Nicholas B. Jennings, Xiuhui Chen, Sara Corvigno, Deanna Glassman, Gabriel Lopez-Berestein, Jinsong Liu, Mien-Chie Hung, Anil K. Sood
Publikováno v:
Cell Reports, Vol 38, Iss 4, Pp 110301- (2022)
Summary: Anti-angiogenic therapies, such as anti-VEGF antibodies (AVAs), have shown promise in clinical settings. However, adaptive resistance to such therapies occurs frequently. We use orthotopic ovarian cancer models with AVA-adaptive resistance t
Externí odkaz:
https://doaj.org/article/d56e8ff2f87f4a398192d9812e8a3e98
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
International Journal of Gynecologic Cancer. 33:420-429
The clinical development of antibody drug conjugates (ADCs) in ovarian cancer began in 2008 with farletuzumab, a humanized monoclonal antibody, and vintafolide, an antigen drug conjugate, both targeting alpha folate receptor. Over the years, this nov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53419558f776289ed4723f7a68237380
https://doi.org/10.1136/ijgc-2022-003701
https://doi.org/10.1136/ijgc-2022-003701